Getting aggressive with prostate cancer

Margot Kim Image
Sunday, June 21, 2015
Getting aggressive with prostate cancer
After skin cancer, prostate cancer is the most common cancer in the United States, affecting one in seven men.

FRESNO, Calif. (KFSN) -- After skin cancer, prostate cancer is the most common cancer in the United States, affecting one in seven men. With more American men living well into their 70s and 80s, a new study by researchers at the University of Pennsylvania found big benefits to aggressively fighting prostate cancer in elderly patients.

Bernie McCauley dotes on his grandkids and loves spending time tinkering on his baby, a 1979 MGB Roadster. At age 70, McCauley says he still has a lot of miles left.

"I keep telling everybody, I haven't felt this good in 35 years," McCauley told ABC30.

McCauley survived throat cancer in 2012 and is battling aggressive prostate cancer right now. At first, he didn't like his treatment options. He explained, "Radiation, chemo, or take my chances and outlive it."

Instead of watching and waiting, McCauley wanted a more aggressive approach.

Justin Bekelman, MD, Radiation Oncologist at the University of Pennsylvania, School of Medicine says in many cases, standard treatment for aggressive prostate cancer in men over the age of 65 is hormone therapy alone.

"We can do better," Dr. Bekelman told ABC30.

Instead, Dr. Bekelman is studying the benefits of adding radiation therapy to hormone treatment in older patients.

"The use of curative treatments is still incredibly important, and it's effective," he said.

Dr. Bekelman found that adding radiation to hormone therapy reduced death in elderly patients by about 50 percent. He says patients do need to weigh the chances of cure against long-term side effects of radiation: erection, bowel and bladder problems.

For McCauley, the decision was easy. He exclaimed, "Don't be afraid of radical, new treatment." He's hoping this adds years to his life, in addition to the life in his years.

Dr. Bekelman says two landmark clinical trials have shown that radiation and hormone therapy provided a significant improvement in survival in younger men, but until now, there has been no research on treatment for older men.

For more information on this report, please contact:

Steve Graff
Media Relations
215-349-5653
Stephen.graff@uphs.upenn.edu